Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Clinical Application of Sleeping Beauty and…
JoVE Journal
Immunology and Infection

This content is Open Access.

JoVE Journal Immunology and Infection
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
 

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Article DOI: 10.3791/50070-v • 09:29 min • February 1st, 2013
February 1st, 2013 •
1, 1, 1, 1, 2, 2, 2, 1, 1
1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center

Chapters

Summary
Automatic Translation

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

Tags

Keywords: Sleeping Beauty Artificial Antigen Presenting Cells Genetic Modification T Cells Peripheral Blood Umbilical Cord Blood CAR T Cells CD19 Gene Therapy Immunotherapy Tumor-associated Antigens Clinical Application
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter